
John Lilleyman

Sir John Stuart Lilleyman FRCP, FRCPE, FRCPath, FRCPCH, FMedSci (born 9 July 1945) is a British paediatric haematologist. He specialization is the childhood leukemia.
In 1991, the Royal College of Pathologists awarded him its first Distinguished Service Medal for establishing the United Kingdom's system of pathology laboratory accreditation.He greatly contributed to the testing of leukemia treatment methods and conducted the unique 
researches on "thiopurine metabolism" which was made on children suffered with leukemia. Other branch of medicine that is of great interest to him is childhood ITP, where he feels qualms about the early treatment of this disease with the help of immunoglobulin.
He served as President of the Royal Society of Medicine from 2004 to 2006.
Being the President of the Royal College of Pathologists he has also the role of Vice-Chairman of the Academy of the Medical Royal Colleges.
In 2004 with the difference of three months he became medical director of the National Patient Safety Agency (NPSA) and the president of the Royal Society of Medicine 
At the moment he works as strategic Advisor to the National Research Ethics Service.